EP15.17: Non‐invasive management of maternal cytomegalovirus infection during pregnancy
Ultrasound in Obstetrics & Gynecology(2019)
摘要
Problem statement Primary maternal cytomegalovirus (CMV) infection occurs in 0.8-6% of all pregnancy worldwide. The vertical transmission rate is 32%. 87.3% of CMV-infected newborns are asymptomatic at birth and 10-15% of these will develop CMV-related sequelae, particularly sensorineural hearing loss (SNHL). Up until now, no antenatal treatment of CMV infection has been satisfactorily validated. Amniocentesis, the gold standard to confirm fetal congenital infection, does neither completely discriminate between infected and uninfected newborn, nor does it predict neurological outcome. For these reasons, it is considered an invasive method and the indication in asymptomatic foetuses is still debated. We propose a first-line non-invasive fetal management using systematic ultrasound (US) and cerebral magnetic resonance imaging (MRI) for primary maternal CMV infection. An amniocentesis is performed only if the medical imaging screening highlights abnormal findings.
更多查看译文
关键词
maternal cytomegalovirus infection,pregnancy
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要